دورية أكاديمية
أعرض في EDS

Greater Risk of Serious Bleeding With Diltiazem vs. Metoprolol in Adults With Atrial Fibrillation Using Apixaban or Rivaroxaban.

التفاصيل البيبلوغرافية
العنوان: Greater Risk of Serious Bleeding With Diltiazem vs. Metoprolol in Adults With Atrial Fibrillation Using Apixaban or Rivaroxaban.
المؤلفون: Slawson DC
المصدر: American family physician [Am Fam Physician] 2024 Aug; Vol. 110 (2), pp. 203.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: American Academy of General Practice Country of Publication: United States NLM ID: 1272646 Publication Model: Print Cited Medium: Internet ISSN: 1532-0650 (Electronic) Linking ISSN: 0002838X NLM ISO Abbreviation: Am Fam Physician Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Kansas City, Mo., American Academy of General Practice.
مواضيع طبية MeSH: Atrial Fibrillation*/drug therapy , Atrial Fibrillation*/complications , Rivaroxaban*/adverse effects , Rivaroxaban*/therapeutic use , Pyridones*/adverse effects , Pyridones*/therapeutic use , Pyrazoles*/adverse effects , Pyrazoles*/therapeutic use , Hemorrhage*/chemically induced , Hemorrhage*/prevention & control , Diltiazem*/adverse effects , Diltiazem*/therapeutic use , Metoprolol*/adverse effects , Metoprolol*/therapeutic use, Humans ; Female ; Male ; Factor Xa Inhibitors/adverse effects ; Factor Xa Inhibitors/therapeutic use ; Aged ; Middle Aged
المشرفين على المادة: 3Z9Y7UWC1J (apixaban)
9NDF7JZ4M3 (Rivaroxaban)
0 (Pyridones)
0 (Pyrazoles)
EE92BBP03H (Diltiazem)
GEB06NHM23 (Metoprolol)
0 (Factor Xa Inhibitors)
تواريخ الأحداث: Date Created: 20240822 Date Completed: 20240822 Latest Revision: 20240920
رمز التحديث: 20240921
PMID: 39172685
قاعدة البيانات: MEDLINE
الوصف
تدمد:1532-0650